Population
Solid organ and hematopoietic stem cell transplant recipients and immunocompromised hosts
Design
Review
Authors
Loading...
May support early antivirals in transplant recipients; leaves open need for randomized confirmation before practice change.
In transplant recipients with poor vaccine responses, antiviral prophylaxis and early therapy appear to be effective strategies for preventing and treating influenza.
Michael G. Ison (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: